Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07535892

Scalable Behavioral Program for Weight Loss Maintenance After GLP-1 and Anti-Obesity Medication Discontinuation

Pilot Trial of a Scalable Behavioral Program for Weight Loss Maintenance After GLP-1 and Anti-Obesity Medication Discontinuation

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
64 (estimated)
Sponsor
University of Alabama at Birmingham · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study is a single-site, pilot randomized factorial trial designed to evaluate the feasibility, acceptability, participant perceptions and preliminary effects of a multi-component behavioral intervention to support weight loss maintenance following discontinuation of GLP-1 and other anti-obesity medications. The intervention includes a standardized 10-week foundational weight loss maintenance program combined with candidate support components, including medically tailored meals, YMCA membership, and a structured mind-based program. Participants will be randomized using a 2 × 2 × 2 factorial design and followed for six months. Findings from this pilot study will inform optimization of a scalable intervention for future clinical trials.

Conditions

Interventions

TypeNameDescription
BEHAVIORALWeight Loss Maintenance Program (Foundational)All participants will receive a standardized 10-week foundational weight loss maintenance program designed to address three key domains: food, physical activity, and mind-based practices. This foundational program is intended to support the transition from active weight loss to long-term weight maintenance.
BEHAVIORALMom's MealsMedically tailored meals
BEHAVIORALYMCA MembershipYMCA membership to support physical activity
BEHAVIORALSKY Meditation ProgramThe SKY Meditation program to support mind-based practices

Timeline

Start date
2026-06-01
Primary completion
2028-11-30
Completion
2029-02-28
First posted
2026-04-17
Last updated
2026-04-17

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT07535892. Inclusion in this directory is not an endorsement.